Renalytix plc Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Renalytix plc (RENXF) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $1.62 per share for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2024-11-19
- Renalytix plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-09-30 was $1.62, a 75.82% decline year-over-year.
- Renalytix plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-09-30 was $6.70, a 47.49% decline year-over-year.
- Renalytix plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2022-09-30 was $12.76.
- Renalytix plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $2.83, a 71.30% decline from fiscal 2023.
- Renalytix plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $9.86.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-09-30 | $1.62 10-Q · filed 2024-11-19 | |||
| 2024-06-30 | $2.83 10-K · filed 2024-09-30 | |||
| 2024-03-31 | $5.39 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $5.48 10-Q · filed 2024-02-14 | |||
| 2023-09-30 | $6.70 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $9.86 10-K · filed 2023-09-28 | |||
| 2023-03-31 | $9.77 6-K · filed 2023-06-09 | |||
| 2022-12-31 | $8.43 6-K · filed 2023-03-30 | |||
| 2022-09-30 | $12.76 6-K · filed 2022-11-30 | |||
| 2022-06-30 | $7.34 20-F · filed 2022-10-31 | |||
| 2022-03-31 | $6.67 6-K · filed 2022-06-30 | |||
| 2021-12-31 | $6.67 6-K/A · filed 2022-04-29 |